Search - tctmd.com

Displaying 141 - 160 of 161

Sort: Relevancy | Date

Presentation TCT 2012

Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES?

Presenter: Dean Kereiakes

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

Presentation

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Presenter: 53202|Dean Kereiakes

March 28, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

Presentation TCT 2012

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

Presenter: Dean J. Kereiakes, Louis A. Cannon, John A. Ormiston, Hong Wang, Paul L. Underwood, Keith D. Dawkins

January 03, 2012

Presentation TCT 2012

Long-Term Follow-up of the Platinum Chromium TAXUS Element (ION) Stent: PERSEUS Two-Year Results.

Presenter: Louis A. Cannon, Dean J. Kereiakes, Wayne Batchelor, Albert Deibele, James Hopkins, Robert E. Foster, Paul Underwood, Keith D. Dawkins

January 03, 2012

News Industry News

Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program

November 07, 2011

News Conference News

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

November 06, 2011

News Industry News

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

November 01, 2011

News Industry News

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

May 25, 2011

News Industry News

Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data

April 03, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Industry News

Boston Scientific Announces its ACC 2011 Schedule

March 29, 2011

News Industry News

Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent

January 25, 2011

Video

» Interview

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

October 18, 2020

Video

» Interview

DISRUPT CAD III: A deep dive on the U.S. pivotal study for coronary IVL

October 16, 2020

Partner Content

TopShock 2019: The Most Challenging Cases Simplified With IVL - Shockwave Medical

December 11, 2019

Partner Content

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

May 17, 2019

Partner Content

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - OUS

April 23, 2019

Partner Content

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - US

April 23, 2019

Advertisement

Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES?

COURAGE, FAME: Revascularization More Effective Than OMT

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

Long-Term Follow-up of the Platinum Chromium TAXUS Element (ION) Stent: PERSEUS Two-Year Results.

Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Boston Scientific Announces its ACC 2011 Schedule

Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

DISRUPT CAD III: A deep dive on the U.S. pivotal study for coronary IVL

TopShock 2019: The Most Challenging Cases Simplified With IVL - Shockwave Medical

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - OUS

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content